256 related articles for article (PubMed ID: 18182992)
1. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study.
Strasser F; Lutz TA; Maeder MT; Thuerlimann B; Bueche D; Tschöp M; Kaufmann K; Holst B; Brändle M; von Moos R; Demmer R; Cerny T
Br J Cancer; 2008 Jan; 98(2):300-8. PubMed ID: 18182992
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.
Garcia JM; Friend J; Allen S
Support Care Cancer; 2013 Jan; 21(1):129-37. PubMed ID: 22699302
[TBL] [Abstract][Full Text] [Related]
3. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.
Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E
J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial.
Miki K; Maekura R; Nagaya N; Nakazato M; Kimura H; Murakami S; Ohnishi S; Hiraga T; Miki M; Kitada S; Yoshimura K; Tateishi Y; Arimura Y; Matsumoto N; Yoshikawa M; Yamahara K; Kangawa K
PLoS One; 2012; 7(5):e35708. PubMed ID: 22563468
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial.
Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS
Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.
Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG
J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial.
Hunter CN; Abdel-Aal HH; Elsherief WA; Farag DE; Riad NM; Alsirafy SA
J Pain Symptom Manage; 2021 Dec; 62(6):1207-1215. PubMed ID: 34051293
[TBL] [Abstract][Full Text] [Related]
8. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
[TBL] [Abstract][Full Text] [Related]
9. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study.
Feliu J; González-Barón M; Berrocal A; Artal A; Ordóñez A; Garrido P; Zamora P; García de Paredes ML; Montero JM
Am J Clin Oncol; 1992 Oct; 15(5):436-40. PubMed ID: 1524045
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.
Akamizu T; Kangawa K
Peptides; 2011 Nov; 32(11):2295-300. PubMed ID: 21635929
[TBL] [Abstract][Full Text] [Related]
12. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
13. Natural ghrelin in advanced cancer patients with cachexia, a case series.
Blum D; de Wolf-Linder S; Oberholzer R; Brändle M; Hundsberger T; Strasser F
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):506-516. PubMed ID: 33452750
[TBL] [Abstract][Full Text] [Related]
14. Anamorelin for cancer cachexia.
Nishie K; Sato S; Hanaoka M
Drugs Today (Barc); 2022 Mar; 58(3):97-104. PubMed ID: 35274629
[TBL] [Abstract][Full Text] [Related]
15. Acute intravenous acyl ghrelin infusion induces thirst but does not affect sodium excretion: two randomized, double-blind, placebo-controlled crossover studies in hypopituitary patients.
Vestergaard ET; Møller N; Andersen RF; Rittig S; Jørgensen JOL
Eur J Endocrinol; 2019 Jul; 181(1):23-30. PubMed ID: 31075759
[TBL] [Abstract][Full Text] [Related]
16. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
Temel JS; Abernethy AP; Currow DC; Friend J; Duus EM; Yan Y; Fearon KC
Lancet Oncol; 2016 Apr; 17(4):519-531. PubMed ID: 26906526
[TBL] [Abstract][Full Text] [Related]
17. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
[TBL] [Abstract][Full Text] [Related]
18. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.
Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH
J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease.
Cheung WW; Mak RH
Kidney Int; 2009 Jul; 76(2):135-7. PubMed ID: 19564855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
